Re: [balita-anda] Vaksin Flu Burung
Mbak Rachma, Di kantor saya kurang lebih 2 tahun yang lalu ada program seperti ini. Untuk mengatasi flu burung. Tapi pada kenyataannya yang divaksinkan adalah vaksin flu, vaksin ini hanya mengandung sekitar 30-40% virus flu yang ada, jadi ya setelah divaksin, masih punya peluang 60-70% untuk kena flu. Pengalaman waktu itu sih, banyak yg kena flu malah setelah sebulan divaksin, jadi kesimpulannya gak ngefek. Vaksin flu ini sangat berguna di negara 4 musim, model eropa atau amerika, yang mengenal flu musiman. Jadi ya mau divaksin monggo, gak divaksin juga gak apa2. Boleh koq usia 3 tahun divaksin, yang gak boleh itu di bawah 6 bulan. best regards, mama Nayma On 2/20/08, Rachma Marlina [EMAIL PROTECTED] wrote: Dear Parents, Ada yang pernah denger tentang Vaksin untuk Flu Burung ga ? Btw, dikantor ku mau diadakan Vaksin untuk Flu Burung, dan kantorku meminta bagi yang berkeluarga bisa memvaksin suami/istri beserta anaknya. Nah kebetulan anak ku RAYHAN kan baru 3 tahun, khawatir aja kalau ga cocok / ada efek samping nya gitu.. Bagi yang dah punya pengalaman vaksin ini untuk para si kecil kita, Please share doong... Thanks Bunda Rayhan
Re: [balita-anda] Vaksin Flu Burung
Tambahan dari imel saya, sampai saat ini belum ada vaksin flu burung. Terus fungsinya divaksin flu biar kenapa? kata dokter kantor sih biar kalo kita kena flu burung, itu virus gak berkembang lebih lanjut menjadi virus yang menular antar manusia (selama ini kan dari hewan ke manusia), kalau sudah antar manusia, walah efeknya jadi panjang kali lebar, bisa jadi pandemi, dan akan banyak korban jiwa. Setelah ditelaah lebih lanjut, kantor saya gak melanjutkan lagi program vaksinasi flu setelah 2 tahun (dgn alasan seperti imel sy sebelumnya ya). On 2/20/08, Lif Rahayu [EMAIL PROTECTED] wrote: Mbak Rachma, Di kantor saya kurang lebih 2 tahun yang lalu ada program seperti ini. Untuk mengatasi flu burung. Tapi pada kenyataannya yang divaksinkan adalah vaksin flu, vaksin ini hanya mengandung sekitar 30-40% virus flu yang ada, jadi ya setelah divaksin, masih punya peluang 60-70% untuk kena flu. Pengalaman waktu itu sih, banyak yg kena flu malah setelah sebulan divaksin, jadi kesimpulannya gak ngefek. Vaksin flu ini sangat berguna di negara 4 musim, model eropa atau amerika, yang mengenal flu musiman. Jadi ya mau divaksin monggo, gak divaksin juga gak apa2. Boleh koq usia 3 tahun divaksin, yang gak boleh itu di bawah 6 bulan. best regards, mama Nayma On 2/20/08, Rachma Marlina [EMAIL PROTECTED] wrote: Dear Parents, Ada yang pernah denger tentang Vaksin untuk Flu Burung ga ? Btw, dikantor ku mau diadakan Vaksin untuk Flu Burung, dan kantorku meminta bagi yang berkeluarga bisa memvaksin suami/istri beserta anaknya. Nah kebetulan anak ku RAYHAN kan baru 3 tahun, khawatir aja kalau ga cocok / ada efek samping nya gitu.. Bagi yang dah punya pengalaman vaksin ini untuk para si kecil kita, Please share doong... Thanks Bunda Rayhan
RE: [balita-anda] Vaksin Flu Burung
Harganya kurang lebih berkisar 900 rb - 1,2 jt. Vaksin ini emang sudah terbukti efektif untuk di LN namun Vaksin ini masih dikembangkan di indo blum ada penelitian ttg keefektifan vaksin ini di Indo. Patty From: lia [EMAIL PROTECTED] Reply-To: balita-anda@balita-anda.com To: balita-anda@balita-anda.com Subject: [balita-anda] Vaksin Flu Burung Date: Wed, 6 Sep 2006 20:44:57 -0700 (PDT) Bapak/Ibu , Anak saya disarankan utk divaksin Prevenar oleh Dokternya , katanya utk mencegah flu burung . Mohon tanya , apakah ada yg sdh pernah anaknya disuntik vaksin ini dan apakah benar flu burung sudah ada vaksinnya ya , dan harganya berapaan . Soalnya saya mau cari data dulu sblm pemberian vaksin ke anak saya . Thanks. Lia __ Do You Yahoo!? Tired of spam? Yahoo! Mail has the best spam protection around http://mail.yahoo.com -- Kirim bunga, http://www.indokado.com Info balita: http://www.balita-anda.com Peraturan milis, email ke: [EMAIL PROTECTED] menghubungi admin, email ke: [EMAIL PROTECTED] _ Express yourself instantly with MSN Messenger! Download today it's FREE! http://messenger.msn.click-url.com/go/onm00200471ave/direct/01/ -- Kirim bunga, http://www.indokado.com Info balita: http://www.balita-anda.com Peraturan milis, email ke: [EMAIL PROTECTED] menghubungi admin, email ke: [EMAIL PROTECTED]
Re: [balita-anda] Vaksin Flu Burung
Bu, TIDAK ADA VAKSIN FLU BURUNG, yang ada hanyalah vaksin influenza. Di kantor saya sedang digalakkan vaksin influenza, dan ini pun hanya mencegah 30-35% virus flu yang ada, karena virus flu buanyak sekali. Lumayan mahal lho, saya kurang tahu berapa, soalnya, dapetnya gratisan. Menurut penjelasa dokter kantor saya, kenapa perlu diberi vaksin influenza, lha wong gak mencegah flu burung lhoo. Jawabnya: vaksin influenza diberikan agar vaksin flu type B atau C (yang biasa ada di manusia), pada saat tubuh manusia kena vrus flu type A (flu burung etc), tidak bermutasi dan menyebabkan munculnya virus flu baru yang lebih ganas dan bisa menular dari manusia ke manusia, karena saat ini flu burung baru dapat ditularkan dari hewan ke manusia, belum manusia ke manusia. kalau sudah bisa ditularkan dari manusia ke manuisa, wah, bisa jadi wabah pandemik nantinya... begitu, Bu. On 9/7/06, Patty Haris [EMAIL PROTECTED] wrote: Harganya kurang lebih berkisar 900 rb - 1,2 jt. Vaksin ini emang sudah terbukti efektif untuk di LN namun Vaksin ini masih dikembangkan di indo blum ada penelitian ttg keefektifan vaksin ini di Indo. Patty From: lia [EMAIL PROTECTED] Reply-To: balita-anda@balita-anda.com To: balita-anda@balita-anda.com Subject: [balita-anda] Vaksin Flu Burung Date: Wed, 6 Sep 2006 20:44:57 -0700 (PDT) Bapak/Ibu , Anak saya disarankan utk divaksin Prevenar oleh Dokternya , katanya utk mencegah flu burung . Mohon tanya , apakah ada yg sdh pernah anaknya disuntik vaksin ini dan apakah benar flu burung sudah ada vaksinnya ya , dan harganya berapaan . Soalnya saya mau cari data dulu sblm pemberian vaksin ke anak saya . Thanks. Lia __ Do You Yahoo!? Tired of spam? Yahoo! Mail has the best spam protection around http://mail.yahoo.com -- Kirim bunga, http://www.indokado.com Info balita: http://www.balita-anda.com Peraturan milis, email ke: [EMAIL PROTECTED] menghubungi admin, email ke: [EMAIL PROTECTED] _ Express yourself instantly with MSN Messenger! Download today it's FREE! http://messenger.msn.click-url.com/go/onm00200471ave/direct/01/ -- Kirim bunga, http://www.indokado.com Info balita: http://www.balita-anda.com Peraturan milis, email ke: [EMAIL PROTECTED] menghubungi admin, email ke: [EMAIL PROTECTED]
Re: [balita-anda] Vaksin Flu Burung
programmes, which are aimed mostly at infants and pregnant women. Access to the vaccines is likely to be an issue in developing countries due to limited resources for the implementation of vaccination programmes. *Prospects:* Both vaccines may be licensed within one or two years in the United States and Europe. Discussions are ongoing about collecting the necessary data for introducing the vaccines into developing countries. Their systematic use in developing countries may well depend on local epidemiology, acceptability, financial resources, and the feasibility of vaccinating adolescents. Meningococcal meningitis A (Men A) The African meningitis belt - which includes all or part of 21 countries stretching south of the Sahara desert from Senegal to Ethiopia - is the site of frequent epidemics, usually caused by serogroup A meningitis. Over the past decade more than 700 000 cases have been reported. Roughly 10-20 % of persons infected die, and one out of five survivors is likely to suffer from a permanent disability such as hearing loss, mental retardation, or paralysis. The rate of meningitis epidemics in the region has increased in recent years. *Status of vaccine development:* Polysaccharide vaccines (vaccines made from complex sugars taken from the outer coats of the Men bacterium) are currently in use, but are not very effective at protecting young children, do not create long-lasting immunity, and do not confer a herd effect - that is, do not prevent spread of the disease in non-vaccinated people through reduction of the carriage of the infectious agent by vaccinated people during epidemics. Because of these shortcomings, immunization with polysaccharide vaccines is usually undertaken only after the onset of an epidemic. To provide greater and more efficient protection, a public-private effort called the Meningitis Vaccine Project (MVP) is developing a Men A conjugate vaccine. This vaccine is intended to have long-lasting effect, to create immunity in infants, and to allow protection to be conferred in advance through mass immunization programmes. Toxicology studies and animal studies have been successfully completed, and the animal studies suggest the conjugate vaccine is highly immunogenic - that is, stimulates high levels of antibodies against Men A infection. Phase I trials will begin in May 2005 in India. Other conjugate vaccines, including a tetravalent vaccine covering serogroups A, C, Y, and W135, are being developed by the private sector; and a tetravalent vaccine has recently been licensed by Sanofi-Pasteur in the United States. *Challenges:* Clinical development of the Men A conjugate vaccine must still be carried out - it must be shown to be safe and effective in humans in Phase I, II, and III trials. In addition, other meningococcal meningitis strains are circulating in Africa which will not be controlled by a vaccine for serogroup A. One strain, referred to as W135, has recently caused epidemics in Burkina Faso and has become more prevalent, although its long-term potential as an epidemic agent is not known. *Prospects:* A low-priced conjugate vaccine for Men A may be ready for widespread use in the African meningitis belt by 2008 or 2009, thanks to an innovative arrangement for development and production. The vaccine was designed by the Center for Biological Evaluation and Research of the United States Food and Drug Administration. The technology was then transferred without intellectual property charges to the Serum Institute of India, which carries out production at the lower costs prevailing in a developing country. The Serum Institute uses raw materials (group A polysaccharides) supplied by SynCo Bio Partners of the Netherlands. The arrangement is expected to keep costs as low as US$ 0.40 per dose, making the vaccine affordable for low-income countries. Much of this vaccine-development project was underwritten by a US$ 70 million grant from the Bill Melinda Gates Foundation. WHO Initiative for Vaccine Research (IVR) The WHO Initiative for Vaccine Research was established in 2001 to streamline the various vaccine research and development projects being carried out by different departments of WHO (including the Special Programme for Research and Training in Tropical Diseases: TDR) and UNAIDS. IVR also provides leadership, priority setting, and coordination among efforts worldwide to develop vaccines against neglected diseases, particularly diseases endemic in developing countries. In addition to collaboration within WHO, IVR works in close association with international organizations, philanthropic organizations, academic medical institutions, and private- and public-sector partners active in the research and development of vaccines. [Non-text portions of this message have been removed] From: Lif Rahayu [EMAIL PROTECTED] Reply-To: balita-anda@balita-anda.com To: balita-anda@balita-anda.com Subject: Re: [balita-anda] Vaksin Flu Burung Date: Thu, 7 Sep 2006 10:53:28 +0700 Bu
